2025-05-01 2026-04-30 false true Capium Accounts Production 1.1 14074050 2025-05-01 2026-04-30 14074050 bus:AbridgedAccounts 2025-05-01 2026-04-30 14074050 bus:FRS102 2025-05-01 2026-04-30 14074050 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 14074050 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 14074050 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 14074050 2025-05-01 2026-04-30 14074050 2026-04-30 14074050 bus:RegisteredOffice 2025-05-01 2026-04-30 14074050 core:WithinOneYear 2026-04-30 14074050 core:AfterOneYear 2026-04-30 14074050 1 2025-05-01 2026-04-30 14074050 bus:Director1 2025-05-01 2026-04-30 14074050 bus:Director1 2026-04-30 14074050 bus:Director1 2024-05-01 2025-04-30 14074050 bus:Director2 2025-05-01 2026-04-30 14074050 bus:Director2 2026-04-30 14074050 bus:Director2 2024-05-01 2025-04-30 14074050 2024-05-01 14074050 bus:LeadAgentIfApplicable 2025-05-01 2026-04-30 14074050 2024-05-01 2025-04-30 14074050 2025-04-30 14074050 core:WithinOneYear 2025-04-30 14074050 core:AfterOneYear 2025-04-30 14074050 bus:EntityAccountantsOrAuditors 2024-05-01 2025-04-30 14074050 core:FurnitureFittings 2025-05-01 2026-04-30 14074050 core:FurnitureFittings 2026-04-30 14074050 core:FurnitureFittings 2025-04-30 14074050 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-04-30 14074050 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-04-30 14074050 core:NetGoodwill 2025-05-01 2026-04-30 14074050 core:NetGoodwill 2026-04-30 14074050 core:NetGoodwill 2025-04-30 14074050 core:CostValuation core:Non-currentFinancialInstruments 2026-04-30 14074050 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 14074050 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-04-30 14074050 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 14074050 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 14074050 core:Non-currentFinancialInstruments 2026-04-30 14074050 core:Non-currentFinancialInstruments 2025-04-30 14074050 core:ShareCapital 2026-04-30 14074050 core:ShareCapital 2025-04-30 14074050 core:RetainedEarningsAccumulatedLosses 2026-04-30 14074050 core:RetainedEarningsAccumulatedLosses 2025-04-30 14074050 dpl:Item1 2025-05-01 14074050 dpl:Item1 2026-04-30 14074050 dpl:Item1 2024-05-01 14074050 dpl:Item1 2025-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14074050
England and Wales

 

 

 


Abridged Accounts

for the year ended 30 April 2026

for

VISANTA HEALTH LIMITED

 
 
Notes
 
2026
£
  2025
£
Fixed assets      
Intangible fixed assets 3 48,370    48,370 
Tangible fixed assets 4 5,225    3,710 
Investments 5 25,000    25,000 
78,595    77,080 
Current assets      
Debtors 5,005    3,144 
Cash at bank and in hand 31,578    21,130 
36,583    24,274 
Creditors: amount falling due within one year (13,574)   (13,707)
Net current assets 23,009    10,567 
 
Total assets less current liabilities 101,604    87,647 
Provisions for liabilities (1,306)   (928)
Net assets 100,298    86,719 
 

Capital and reserves
     
Called up share capital 200    200 
Profit and loss account 100,098    86,519 
Shareholders' funds 100,298    86,719 
 


For the year ended 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 30 October 2026 and were signed on its behalf by:


-------------------------------
JP Bannard-Smith
Director
1
General Information
Visanta Health Limited is a private company, limited by shares, registered in England and Wales, registration number 14074050, registration address .

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The companys liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Dividends
Proposed dividends are only included as liabilities in the balance sheet when their payment has been approved by the shareholders prior to the balance sheet date.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
The director does not consider there to be any impairment of goodwill during the period.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Equipment 33% Straight Line
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the period was 0 (2025 : 0).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 May 2025 48,370    48,370 
Additions -    - 
Disposals -    - 
At 30 April 2026 48,370    48,370 
Net book values
At 30 April 2026 48,370    48,370 
At 30 April 2025 48,370    48,370 


4.

Tangible fixed assets

Cost or valuation Fixtures and Equipment   Total
  £   £
At 01 May 2025 5,845    5,845 
Additions 5,195    5,195 
Disposals -    - 
At 30 April 2026 11,040    11,040 
Depreciation
At 01 May 2025 2,135    2,135 
Charge for year 3,680    3,680 
On disposals -    - 
At 30 April 2026 5,815    5,815 
Net book values
Closing balance as at 30 April 2026 5,225    5,225 
Opening balance as at 01 May 2025 3,710    3,710 


5.

Investments

Cost Investments in group undertakings   Total
  £   £
At 01 May 2025 25,000    25,000 
Additions -    - 
Disposals -    - 
At 30 April 2026 25,000    25,000 

6.

Controlling Parties

The company is controlled by the directors.


2